CEL-SCI closes $2.5M stock offering at $1.00 per share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/28/2026
- S&P 500 ends lower; chips tumble and Moderna rallies
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
CEL-SCI Announces Closing of Offering
June 16, 2026 4:01 PM EDTVIENNA, Va.--(BUSINESS WIRE)--
CEL-SCI Corporation (CEL-SCI or the Company) (NYSE American: CVM), a clinical stage cancer immunotherapy company, today announced the closing of its best-efforts offering of 2,500,000 shares of its common stock. Each share of common stock was sold at an offering price of $1.00 per share. Total gross proceeds from the offering, before deducting the placement agents fees and other offering expenses, were approximately $2.5 million.
The Company intends to use the net proceeds from the offering to fund the continued development of Multikine*,... More
